Skip to main content
AmigoFish

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

From Courtroom Daily · · 4 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

The United States Food and Drug Administration has issued a formal directive to manufacturers of popular GLP-1 weight-loss and diabetes medications. These companies are now required to update their product labels to include warnings about a rare, potentially serious eye condition that can lead to sudden and permanent vision loss.

Back to Courtroom Daily · Report a problem